Title |
Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
|
---|---|
Published in |
Journal for Immunotherapy of Cancer, March 2017
|
DOI | 10.1186/s40425-017-0230-9 |
Pubmed ID | |
Authors |
Irene Scarfò, Marcela V. Maus |
Abstract |
Chimeric antigen receptor (CAR) T-cell therapy represents a revolutionary treatment for haematological malignancies (i.e. B-ALL). However, the success of this type of treatment has not yet been achieved in solid tumors. One hypothesis is that the immunosuppressive nature of the tumor microenvironment (TME) influences and affects the efficacy of adoptive immunotherapy. Understanding the role of the TME and its interaction with CAR T-cells is crucial to improve the potency of adoptive immunotherapy. In this review, we discuss the strategies and potential combinatorial approaches recently developed in mouse models to enhance the efficacy of CAR T-cells, with particular emphasis on the translational potential of these approaches. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 11 | 33% |
France | 4 | 12% |
Spain | 3 | 9% |
Ireland | 1 | 3% |
Comoros | 1 | 3% |
Chile | 1 | 3% |
Russia | 1 | 3% |
Unknown | 11 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 22 | 67% |
Scientists | 5 | 15% |
Practitioners (doctors, other healthcare professionals) | 3 | 9% |
Science communicators (journalists, bloggers, editors) | 3 | 9% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | <1% |
France | 1 | <1% |
Norway | 1 | <1% |
Japan | 1 | <1% |
United States | 1 | <1% |
Unknown | 295 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 59 | 20% |
Student > Ph. D. Student | 54 | 18% |
Student > Bachelor | 33 | 11% |
Student > Master | 27 | 9% |
Student > Doctoral Student | 20 | 7% |
Other | 46 | 15% |
Unknown | 61 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 62 | 21% |
Immunology and Microbiology | 51 | 17% |
Medicine and Dentistry | 44 | 15% |
Agricultural and Biological Sciences | 30 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 14 | 5% |
Other | 29 | 10% |
Unknown | 70 | 23% |